Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers W > Headlines for Wyeth > News item |
Bear Stearns reiterates Wyeth at market outperform
Wyeth was reiterated by Bear Stearns analyst John Boris at a market outperform rating with a price target of $55 after third-quarter results showed sales growth for Enbrel and Prevnar. Other new product filings and a potential Effexor XR settlement provide major catalysts for future stock growth, Bear Stearns said. Shares of the Madison, N.J., company were up $0.50, or 1.11%, at $45.50 on volume of 5,544,600 shares versus the three-month running average of 3,667,250 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.